Gaboxadol: Difference between revisions
Appearance
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Recategorize: Stimulants & Wake-Promoting Agents -> Stimulants |
MDElliottMD (talk | contribs) Recategorize: Stimulants -> Psychostimulants |
||
| Line 32: | Line 32: | ||
[[Category: | [[Category:Psychostimulants]] | ||
[[Category:GABAergics]] | [[Category:GABAergics]] | ||
[[Category:Sedative-Hypnotics]] | [[Category:Sedative-Hypnotics]] | ||
[[Category:GABAA Positive Allosteric Modulators (General)]] | [[Category:GABAA Positive Allosteric Modulators (General)]] | ||
[[Category:Research Materials]] | [[Category:Research Materials]] | ||
Revision as of 10:50, 17 May 2026
GABAergic, Sedative-Hypnotic
Gaboxadol
THIP
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
GABAergic, Sedative-Hypnotic
Common uses
Pharmacy
Pharmacology
Purported mechanism
Selective GABAA agonist (extrasynaptic delta subunit)